255 related articles for article (PubMed ID: 6099095)
1. Antibody engineering, a strategy for the development of monoclonal antibodies.
Schönherr OT; Houwink EH
Antonie Van Leeuwenhoek; 1984; 50(5-6):597-623. PubMed ID: 6099095
[TBL] [Abstract][Full Text] [Related]
2. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
Foung SK; Perkins S; Raubitschek A; Larrick J; Lizak G; Fishwild D; Engleman EG; Grumet FC
J Immunol Methods; 1984 May; 70(1):83-90. PubMed ID: 6201562
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies: methods and clinical laboratory applications.
Nakamura RM
Clin Physiol Biochem; 1983; 1(2-5):160-72. PubMed ID: 6396016
[TBL] [Abstract][Full Text] [Related]
4. Novel approaches to the preparation and use of monoclonal antibodies.
Lemieux R; Bazin R
Transfus Med Rev; 1993 Jan; 7(1):25-36. PubMed ID: 8381687
[No Abstract] [Full Text] [Related]
5. [Current developments in hybridoma technology].
Osterhaus AD; UytdeHaag AG
Tijdschr Diergeneeskd; 1985 Oct; 110(20):835-9. PubMed ID: 3878011
[TBL] [Abstract][Full Text] [Related]
6. Human monoclonal antibodies: their technology and application.
Blann AD
Med Lab Sci; 1981 Oct; 38(4):389-93. PubMed ID: 6276640
[No Abstract] [Full Text] [Related]
7. Hybridoma technologies for antibody production.
Tomita M; Tsumoto K
Immunotherapy; 2011 Mar; 3(3):371-80. PubMed ID: 21395379
[TBL] [Abstract][Full Text] [Related]
8. [A strategy for the production of human monoclonal antibodies].
Chiba J
Hum Cell; 1988 Mar; 1(1):31-6. PubMed ID: 2856441
[TBL] [Abstract][Full Text] [Related]
9. Generation of Murine Monoclonal Antibodies by Hybridoma Technology.
Holzlöhner P; Hanack K
J Vis Exp; 2017 Jan; (119):. PubMed ID: 28117810
[TBL] [Abstract][Full Text] [Related]
10. Establishment of hybridoma secreting human monoclonal antibody against hepatitis B virus surface antigen.
Ichimori Y; Harada K; Hitotsumachi S; Tsukamoto K
Biochem Biophys Res Commun; 1987 Feb; 142(3):805-12. PubMed ID: 3030301
[TBL] [Abstract][Full Text] [Related]
11. [Human hybridoma neutralizing antibodies to the herpes simplex virus].
Kushch AA; Tugizov ShM; Terletskaia EN; Posevaia TA; Nikitina AA; L'vov ND; Barinskiĭ IF
Vopr Virusol; 1992; 37(5-6):264-6. PubMed ID: 1337804
[TBL] [Abstract][Full Text] [Related]
12. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
Cote RJ; Morrissey DM; Oettgen HF; Old LJ
Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
[TBL] [Abstract][Full Text] [Related]
13. The EBV-hybridoma technique.
Roder JC; Cole SP; Kozbor D
Methods Enzymol; 1986; 121():140-67. PubMed ID: 3014265
[No Abstract] [Full Text] [Related]
14. SPAM-8, a mouse-human heteromyeloma fusion partner in the production of human monoclonal antibodies. Establishment of a human monoclonal antibody against cytomegalovirus.
Gustafsson B; Jondal M; Sundqvist VA
Hum Antibodies Hybridomas; 1991 Jan; 2(1):26-32. PubMed ID: 1651784
[TBL] [Abstract][Full Text] [Related]
15. Human monoclonal antibody by an established human-human hybridoma.
Tsuji K; Ikewaki N; Matsuno N
Transplant Proc; 1987 Feb; 19(1 Pt 1):610-1. PubMed ID: 2856298
[No Abstract] [Full Text] [Related]
16. Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma.
Kozbor D; Roder JC; Chang TH; Steplewski Z; Koprowski H
Hybridoma; 1982; 1(3):323-8. PubMed ID: 6092264
[TBL] [Abstract][Full Text] [Related]
17. High-resolution analysis of the B cell repertoire before and after polyethylene glycol fusion reveals preferential fusion of rare antigen-specific B cells.
Dubois AR; Buerckert JP; Sinner R; Faison WJ; Molitor AM; Muller CP
Hum Antibodies; 2016 Jun; 24(1-2):1-15. PubMed ID: 27472868
[TBL] [Abstract][Full Text] [Related]
18. An extreme strategy for the production of hybridoma.
Golestani R; Pourfathollah AA; Moazzeni SM
Hybridoma (Larchmt); 2009 Apr; 28(2):139-44. PubMed ID: 19249989
[TBL] [Abstract][Full Text] [Related]
19. Stabilizing antibody secretion of human Epstein Barr virus-activated B-lymphocytes with hybridoma formation by electrofusion.
Perkins S; Foung SK
Methods Mol Biol; 1995; 48():295-307. PubMed ID: 8528401
[No Abstract] [Full Text] [Related]
20. Generation of human monoclonal antibodies by fusion of EBV-activated B cells to a human-mouse hybridoma.
Foung SK; Engleman EG; Grumet FC
Methods Enzymol; 1986; 121():168-74. PubMed ID: 3014266
[No Abstract] [Full Text] [Related]
[Next] [New Search]